Phibro Animal Health (PAHC) Cash from Investing Activities Growth (1y) (2014 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn | 24.18% |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn | -41.51% |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | -96.43% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | -133.88% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -133.88% |
| Mar 31, 2026 | 7.92% |
| Dec 31, 2025 | 93.40% |
| Sep 30, 2025 | -617.20% |
| Jun 30, 2025 | 22.80% |
| Mar 31, 2025 | -1,715.13% |
| Dec 31, 2024 | -947.72% |
| Sep 30, 2024 | 80.91% |
| Jun 30, 2024 | 11.39% |
| Mar 31, 2024 | 102.99% |
| Dec 31, 2023 | -153.43% |
| Sep 30, 2023 | 4.94% |
| Jun 30, 2023 | -7.78% |
| Mar 31, 2023 | -279.90% |
| Dec 31, 2022 | -155.84% |
| Sep 30, 2022 | 21.86% |
| Jun 30, 2022 | -32.68% |
| Mar 31, 2022 | -200.76% |
| Dec 31, 2021 | 330.43% |
| Sep 30, 2021 | -51.57% |